February 7, 2020
Couetoux du Tertre et al. Clin Proteom 2020;17:5.
Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibition
You might also be interested by
CellTalk
Landmark study on metastatic breast cancer highlights the importance of identifying HER2-low patients
June 23, 2022
Proteomics/Mass Spectrometry
More infoPress Releases
CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays
May 19, 2022
Proteomics/Mass Spectrometry
More infoBrochures
High Performance Technologies for Cytokine Measurement
November 8, 2021
Immune Monitoring
More info